FDA issues nationwide recall of blood pressure medication after pills fail quality test

Check your medicine cabinets: More than 3,700 bottles of blood pressure medication sold nationwide were recalled last month because the pills fail to break down and dissolve properly, an enforcement report from the Food and Drug Administration said. New Jersey-based Macleods Pharma USA Inc. issued the recall Oct. 7 for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets. The recall was labeled a Class II recall on Oct. 26, meaning the pills could cause temporary or medically reversible health problems, but the likelihood of serious health consequences is considered low. The pills ranged from 40 mg, 10mg and 12.5mg, and were sold in either 30-count or 90-count bottles. Overall, 3,528 30-count bottles were recalled, and 216 90-count bottles were recalled, the report said. The reason for the recall, the report stated, was because of failed dissolution specifications, meaning the pills did not dissolve as required. According to the Mayo Clinic, the prescripti